COMPARISON OF TAMSULOSIN AND SILODOSIN IN TREATMENT OF LOWER URETERIC STONES
Phase 3
- Conditions
- Health Condition 1: N201- Calculus of ureter
- Registration Number
- CTRI/2019/07/019961
- Lead Sponsor
- ARUNCHAND R
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
a) Unilateral distal ureteric calculus
b) Size < 10 mm
c) Normal renal parameters (Serum Urea & Serum Creatinine)
d) Age 18-60 yrs
Exclusion Criteria
a) Single kidney
b) Bilateral ureteric stone
c) Mid/upper ureteric calculus
d) Renal impairment
e) High grade hydroureteronephrosis (Grade III & IV as per Society of Fetal Ultrasound, SFU)
f) Any h/o previous endoscopic/ surgical/ ESWL interventions
g) Intolerable side-effects (Hypotension) to either tamsulosin/ silodosin
h) Evidence of UTI
j) Concomitant kidney/bladder stones
k) Patients already on any alpha blocker for BPH
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method STONE CLEARENCE RATE (%)Timepoint: 1.Passing of stone <br/ ><br>2.04 weeks elapsed and surgical intervention planned <br/ ><br>3.Symptoms of patient demanding interventional procedures
- Secondary Outcome Measures
Name Time Method STONE EXPULSION TIME (DAYS)Timepoint: 1.Passing of stone <br/ ><br>2.04 weeks elapsed and surgical intervention planned <br/ ><br>3.Symptoms of patient demanding interventional procedures